TORONTO, Nov. 8, 2021 /CNW/ - Khiron Life Sciences Corp.
("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated
cannabis leader with core operations in Latin America and Europe, is scheduled to participate in the
following virtual and in-person conferences in November 2021:
CANNABIS EUROPA
Banking Hall, London
November 10-11, 2021
Franziska Katterbach, Europe President attending 1x1 Meetings
Q4 VIRTUAL INVESTOR SUMMIT
November 16 -17,
2021
Khiron Presentation: Tuesday, November
16th at 11:45 a.m.
ET
Webcast:
https://us06web.zoom.us/webinar/register/WN_PF7iJRaJQgyHbM9Z-yNkxA
FLORIDA CAPITAL
EVENT:
Hollywood,
Florida
November 19-21, 2021
Alvaro Torres, CEO and Franziska
Katterbach, Europe President attending 1x1 Meetings
COWEN'S 4TH ANNUAL CANNABIS VIRTUAL
CONFERENCE
November 29 –
December 1, 2021
International Panel Participation: November
30th, 2021 at 11:50 a.m ET
COWEN hosted events are intended for prospective and existing
COWEN clients and management participants only. To listen to the
live event or request 1-on-1 meetings with the Company, please
contact you're Cowen representative with interest.
For more information about the conferences or to schedule a
1-on-1 meeting with Khiron management, please contact the company's
investor relations team at investors@khiron.ca
About Khiron Life Sciences Corp.
Khiron is a leading
vertically integrated international medical cannabis company with
core operations in Latin America
and Europe. Leveraging
wholly-owned medical health clinics and proprietary telemedicine
platforms, Khiron combines a patient-oriented approach, physician
education programs, scientific expertise, product innovation, and
agricultural infrastructure to drive prescriptions and brand
loyalty with patients worldwide. The Company has a sales presence
in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in
Mexico. The Company is led by
Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and
diverse executive team and Board of Directors.
Visit Khiron online at investors.khiron.ca
Linkedin
https://www.linkedin.com/company/khiron-life-sciences-corp/
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment on
analyses, expectations or statements made by third-parties in
respect of Khiron, its securities, or financial or operating
results (as applicable). Although Khiron believes that the
expectations reflected in forward-looking statements in this press
release are reasonable, such forward-looking statement has been
based on expectations, factors and assumptions concerning future
events which may prove to be inaccurate and are subject to numerous
risks and uncertainties, certain of which are beyond Khiron's
control, including the risk factors discussed in Khiron's Annual
Information Form which is available on Khiron's SEDAR profile at
www.sedar.com. The forward-looking information contained in this
press release is expressly qualified by this cautionary statement
and is made as of the date hereof. Khiron disclaims any intention
and has no obligation or responsibility, except as required by law,
to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
Neither the TSXV nor its Regulation Services Provider (as that
term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this press release.
Investor Contact:
Paola Ricardo
E: investors@khiron.ca
T: +1 (647) 556-5750
Media Contact:
Peter
Leis
Europe Communications
E: pleis@khiron.ca
Carolina Gomez
Latam Communications
E: mgomez@khiron.ca
Khiron Europe:
Franziska Katterbach, President
E: fkatterbach@khiron.ca
View original content to download
multimedia:https://www.prnewswire.com/news-releases/khiron-life-sciences-to-present-at-upcoming-november-investor-conferences-301418586.html
SOURCE Khiron Life Sciences Corp.